Lymphoid Enhancer Factor 1 Contributes to Hepatocellular Carcinoma Progression Through Transcriptional Regulation of Epithelial‐Mesenchymal Transition Regulators and Stemness Genes

Lymphoid enhancer factor 1 (LEF1) activity is associated with progression of several types of cancers. The role of LEF1 in progression of hepatocellular carcinoma (HCC) remains poorly known. We investigated LEF1 expression in HCC and its interactions with epithelial‐mesenchymal transition (EMT) regu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chih‐Li, Tsai, Yu‐Shuen, Huang, Yen‐Hua, Liang, Yuh‐Jin, Sun, Ya‐Yun, Su, Chien‐Wei, Chau, Gar‐Yang, Yeh, Yi‐Chen, Chang, Yung‐Sheng, Hu, Jui‐Ting, Wu, Jaw‐Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211324/
https://www.ncbi.nlm.nih.gov/pubmed/30411085
http://dx.doi.org/10.1002/hep4.1229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211324/
https://www.ncbi.nlm.nih.gov/pubmed/30411085
http://dx.doi.org/10.1002/hep4.1229

Ejemplares similares